Trial Profile
Effects of veliflapon on biomarkers of the risk of myocardial infarction.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs Veliflapon (Primary)
- Indications Myocardial infarction
- Focus Pharmacodynamics
- Sponsors deCODE genetics
- 05 Nov 2010 New trial record.